High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma (DBCOND0125704)

Identifiers

Synonyms

High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma / High-Risk Non-Muscle Invasive Bladder Urothelial Carcinoma

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT05276167	Hyperthermic Intravesical Perfusion for Muscle-invasive Bladder Urothelial Carcinoma	No drug interventions	treatment	Not Available	recruiting
NCT05962541	Vesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) to Avoid Secondary Resections (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs)	Hexaminolevulinate	treatment	4	not_yet_recruiting
NCT05843448	IDO and PD-L1 Peptide Based Immune-Modulatory Therapeutic (IO102-IO103) in Combination With Pembrolizumab for BCG-Unresponsive or Intolerant, Non-Muscle Invasive Bladder Cancer	Pembrolizumab	treatment	1	recruiting
NCT05418309	Tilelizumab Combined With Nab-Paclitaxel for High-Risk Non-Muscle-Invasive Urothelial Bladder Carcinoma Which is Not Completely Resectable: a Multi-center Study	Paclitaxel Tislelizumab	treatment	2	unknown_status